IT8567500A0 - Derivati di 1 3 ossazolidin 2 one e procedimenti per la loro preparazione - Google Patents

Derivati di 1 3 ossazolidin 2 one e procedimenti per la loro preparazione

Info

Publication number
IT8567500A0
IT8567500A0 IT8567500A IT6750085A IT8567500A0 IT 8567500 A0 IT8567500 A0 IT 8567500A0 IT 8567500 A IT8567500 A IT 8567500A IT 6750085 A IT6750085 A IT 6750085A IT 8567500 A0 IT8567500 A0 IT 8567500A0
Authority
IT
Italy
Prior art keywords
oxazolidin
procedures
derivatives
preparation
Prior art date
Application number
IT8567500A
Other languages
English (en)
Other versions
IT1208807B (it
Inventor
Mitsuo Masaki Haruhi Shinozaki
Masaru Satoh Naoya Moritoh
Koichi Hashimoto
Toshiro Kamishiro
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of IT8567500A0 publication Critical patent/IT8567500A0/it
Application granted granted Critical
Publication of IT1208807B publication Critical patent/IT1208807B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT8567500A 1984-09-28 1985-05-30 Derivati di 1 3 ossazolidin 2 one e procedimenti per la loro preparazione IT1208807B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59203624A JPS6183170A (ja) 1984-09-28 1984-09-28 新規な１，３−オキサゾリジン−２−オン誘導体およびその製造法

Publications (2)

Publication Number Publication Date
IT8567500A0 true IT8567500A0 (it) 1985-05-30
IT1208807B IT1208807B (it) 1989-07-10

Family

ID=16477122

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8567500A IT1208807B (it) 1984-09-28 1985-05-30 Derivati di 1 3 ossazolidin 2 one e procedimenti per la loro preparazione

Country Status (27)

Country Link
US (1) US4644063A (it)
JP (1) JPS6183170A (it)
KR (1) KR900004323B1 (it)
AR (1) AR240924A1 (it)
AT (1) AT392069B (it)
AU (1) AU566419B2 (it)
BR (1) BR8502707A (it)
CA (1) CA1252092A (it)
CH (1) CH663207A5 (it)
CS (1) CS273606B2 (it)
DE (1) DE3519261C2 (it)
DK (1) DK165952C (it)
ES (2) ES8800571A1 (it)
FR (1) FR2571052B1 (it)
GB (2) GB8512975D0 (it)
HU (1) HU199132B (it)
IN (1) IN162060B (it)
IT (1) IT1208807B (it)
MX (2) MX161397A (it)
MY (1) MY102081A (it)
NL (1) NL193191C (it)
NZ (1) NZ212143A (it)
PH (1) PH20852A (it)
RO (1) RO91422B (it)
SE (1) SE463100B (it)
SU (2) SU1402263A3 (it)
ZA (1) ZA854001B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6183147A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤
JPH0759570B2 (ja) * 1986-05-06 1995-06-28 三井東圧化学株式会社 ２−オキサゾリジノン類の製造方法
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
DE3877470T2 (de) * 1987-09-10 1993-06-24 Merck Sharp & Dohme Oxazole und thiazole zur behandlung seniler demenz.
ATE106243T1 (de) * 1988-03-24 1994-06-15 Sankyo Co Verwendung von isoxazolinonen als cerebro-aktive medikamente.
JPH0314562A (ja) * 1988-04-11 1991-01-23 Nippon Chemiphar Co Ltd 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
DK0579169T3 (da) * 1992-07-14 1999-05-31 Nippon Chemiphar Co Alkylendiaminderivater
WO1995007904A1 (en) * 1993-09-15 1995-03-23 Merck Sharp & Dohme Limited Imidazolone and oxazolone derivatives as dopamine antagonists
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
US6037354A (en) 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
ES2633269T3 (es) 2013-03-14 2017-09-20 Akzo Nobel Chemicals International B.V. Éter de celulosa como agente de control de dispersión y agente de resistencia a la lluvia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2437389A (en) * 1948-03-09 Oxazoeidones and erocesstok
DE1135461B (de) * 1959-05-08 1962-08-30 Knoll Ag Verfahren zur Herstellung von basisch substituierten Phthalimidinen
FR1301267A (fr) * 1961-04-04 1962-08-17 Science Union Et Compagnie Soc Nouveaux dérivés de l'oxazolidinone-2 et leurs procédés de préparation
US3131197A (en) * 1963-03-13 1964-04-28 Smith Kline French Lab 5-(3, 4-carbonyldioxyphenyl)-3-isopropyl-2-oxazolidone
US3576808A (en) * 1967-09-15 1971-04-27 Miles Lab N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
FR2179582B1 (it) * 1972-04-13 1975-10-10 Synthelabo

Also Published As

Publication number Publication date
CS392785A2 (en) 1990-08-14
IN162060B (it) 1988-03-19
RO91422A (ro) 1987-06-30
MX161397A (es) 1990-09-20
MY102081A (en) 1992-03-31
KR900004323B1 (ko) 1990-06-22
MX21592A (es) 1994-01-31
US4644063A (en) 1987-02-17
AR240924A1 (es) 1991-03-27
ATA165685A (de) 1990-07-15
ES8802152A1 (es) 1988-04-01
FR2571052A1 (fr) 1986-04-04
CH663207A5 (fr) 1987-11-30
DK230185A (da) 1986-03-29
HU199132B (en) 1990-01-29
SE463100B (sv) 1990-10-08
DE3519261C2 (de) 1997-01-16
GB2165237B (en) 1987-12-09
CA1252092A (en) 1989-04-04
KR860002502A (ko) 1986-04-26
CS273606B2 (en) 1991-03-12
GB2165237A (en) 1986-04-09
SE8502525D0 (sv) 1985-05-22
SU1402263A3 (ru) 1988-06-07
AU4469785A (en) 1986-04-10
ES543517A0 (es) 1987-11-01
ZA854001B (en) 1986-01-29
GB8512975D0 (en) 1985-06-26
DE3519261A1 (de) 1986-04-10
JPH0469150B2 (it) 1992-11-05
ES8800571A1 (es) 1987-11-01
RO91422B (ro) 1987-07-02
DK230185D0 (da) 1985-05-23
FR2571052B1 (fr) 1988-03-04
SU1431679A3 (ru) 1988-10-15
ES557075A0 (es) 1988-04-01
IT1208807B (it) 1989-07-10
GB8513685D0 (en) 1985-07-03
PH20852A (en) 1987-05-19
NL193191B (nl) 1998-10-01
SE8502525L (sv) 1986-03-29
JPS6183170A (ja) 1986-04-26
BR8502707A (pt) 1986-05-27
DK165952C (da) 1993-07-05
NL8501579A (nl) 1986-04-16
DK165952B (da) 1993-02-15
AU566419B2 (en) 1987-10-22
HUT39168A (en) 1986-08-28
NL193191C (nl) 1999-02-02
NZ212143A (en) 1987-11-27
AT392069B (de) 1991-01-25
AR240924A2 (es) 1991-03-27

Similar Documents

Publication Publication Date Title
AR241161A1 (es) "procedimiento para la preparacion de derivados n-aminoalquilen sustituidos de la glutarimida"
IT8220094A0 (it) Derivati della 3,4-diidro-5h-2,3benzodiazepina e procedimento per la loro preparazione
IT1203635B (it) Derivati di benzonorbonene procedimento per la loro preparazione e composizioni medicinali e cosmetiche che li contengono
IT1187717B (it) Procedimento per la preparazione di derivati 3-sostituiti dell'1-amino-2-idrossi-propano
IT1157104B (it) Procedimento per la preparazione di derivati della 3 alcossimetilcefalosporina
IT8567500A0 (it) Derivati di 1 3 ossazolidin 2 one e procedimenti per la loro preparazione
IT1196488B (it) Poli-4-aminopirrol-2-carbossamido derivati e procedimento per la loro preparazione
PT80264A (fr) Preparation de derives de l'hydroxy-4-2h-1-benzothiopyran-2-one
IT1157298B (it) N-imidazolil derivati di 1,2,3,4-tetraidronaftalene, indano e 2-sostituito-1-cromano e processo per la loro preparazione
IT1185828B (it) Derivati del calcone e procedimento per la loro preparazione
IT8547862A0 (it) Derivati piridinici e procedimenti per la loro preparazione
PT84184A (pt) Process for the preparation of 8 alpha-acylaminoergolines and of pharmaceutical compositions containing them
IT1195830B (it) Derivati di 2 1 2 4 triazolin 5 one procedimento per la loro preparazione composizioni che li contengono e relativi impieghi
IT1214726B (it) Derivati di glucosilmoranolina eprocedimento per la loro preparazione
IT1163943B (it) Derivati 15-cicloalifatici di 13,14-dideidro carboprostacicline e procedimento per la loro preparazione
IT8249765A0 (it) Derivati di amminopropilamminobleomicina e procedimento per la loro preparazione
IT1190711B (it) Derivati di alchilen-diammina e procedimento per la loro preparazione
IT1148788B (it) Derivati dell'amminoisochinolina e procedimento per la loro preparazione
IT8519442A0 (it) Derivati di fenilpropargilammine
IT1213235B (it) Derivati della [1,3] ossazino [4,3a] isochinolina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1200399B (it) 1-nor-2-idrossi-metil-derivati di carboprostacicline e procedimento per la loro preparazione
IT1199830B (it) 10 b-alchinil-4,9(11)-estradiene derivati e procedimento per la loro preparazione
IT8567781A0 (it) Procedimento di preparazione di cefem derivati
IT1200461B (it) Composizioni di farmaci e procedimento per la loro preparazione
IT1185509B (it) Procedimento di preparazione di derivati cefemici

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970530